Lawson Kroeker Investment Management Inc. NE Raises Stock Position in Waters Corporation $WAT

Lawson Kroeker Investment Management Inc. NE grew its stake in Waters Corporation (NYSE:WAT) by 1.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,616 shares of the medical instruments supplier’s stock after purchasing an additional 114 shares during the quarter. Lawson Kroeker Investment Management Inc. NE’s holdings in Waters were worth $3,705,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Olde Wealth Management LLC bought a new position in Waters in the first quarter worth about $25,000. Zions Bancorporation National Association UT purchased a new position in shares of Waters during the 1st quarter worth approximately $28,000. IFP Advisors Inc grew its holdings in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of Waters in the 1st quarter worth approximately $41,000. Finally, Steph & Co. purchased a new position in shares of Waters in the 2nd quarter valued at approximately $73,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Up 0.4%

Shares of Waters stock opened at $331.74 on Friday. The company has a 50-day simple moving average of $299.97 and a two-hundred day simple moving average of $323.89. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The stock has a market capitalization of $19.75 billion, a PE ratio of 29.91, a price-to-earnings-growth ratio of 3.09 and a beta of 1.04.

Waters (NYSE:WAT) last announced its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The company had revenue of $608.55 million during the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. On average, analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Jefferies Financial Group set a $385.00 price target on Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. Wells Fargo & Company dropped their target price on shares of Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Scotiabank reiterated a “sector outperform” rating and issued a $465.00 price target on shares of Waters in a research note on Friday, July 11th. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research note on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Waters has an average rating of “Moderate Buy” and a consensus price target of $377.56.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.